APA (7th ed.) Citation

H, F., MM, A., RB, M., JM, R., MD, K., NL, S., . . . JS, H. (1999). Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: A report from the Children's Cancer Group. Clinical cancer research : an official journal of the American Association for Cancer Research, 5(12), 3956.

Chicago Style (17th ed.) Citation

H, Frangoul, et al. "Phase I Study of Topotecan Administered as a 21-day Continous Infusion in Children with Recurrent Solid Tumors: A Report from the Children's Cancer Group." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 5, no. 12 (1999): 3956.

MLA (9th ed.) Citation

H, Frangoul, et al. "Phase I Study of Topotecan Administered as a 21-day Continous Infusion in Children with Recurrent Solid Tumors: A Report from the Children's Cancer Group." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 5, no. 12, 1999, p. 3956.